IRIS UniCatt

Pompili, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.102
NA - Nord America 7.781
AS - Asia 3.833
SA - Sud America 642
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 27
OC - Oceania 18
Totale 21.470
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.680
DE - Germania 3.366
SE - Svezia 1.694
CN - Cina 1.502
SG - Singapore 1.313
IT - Italia 969
UA - Ucraina 718
BR - Brasile 569
IE - Irlanda 511
FR - Francia 465
GB - Regno Unito 323
ID - Indonesia 302
FI - Finlandia 283
RU - Federazione Russa 232
TR - Turchia 191
IN - India 179
PL - Polonia 168
BE - Belgio 70
CA - Canada 61
KR - Corea 61
NL - Olanda 56
AT - Austria 50
JP - Giappone 43
IR - Iran 37
CZ - Repubblica Ceca 34
HK - Hong Kong 34
CI - Costa d'Avorio 33
VN - Vietnam 25
CH - Svizzera 24
AR - Argentina 23
ES - Italia 23
RO - Romania 22
EU - Europa 21
IL - Israele 18
AU - Australia 16
AE - Emirati Arabi Uniti 15
EC - Ecuador 15
MX - Messico 15
LT - Lituania 14
GR - Grecia 12
IQ - Iraq 12
PE - Perù 12
PT - Portogallo 12
TW - Taiwan 12
KG - Kirghizistan 11
HU - Ungheria 10
PK - Pakistan 9
CL - Cile 8
UZ - Uzbekistan 8
AL - Albania 7
BD - Bangladesh 7
BZ - Belize 7
MA - Marocco 7
PA - Panama 7
PH - Filippine 7
ZA - Sudafrica 7
DK - Danimarca 6
AZ - Azerbaigian 5
CO - Colombia 5
LK - Sri Lanka 5
TZ - Tanzania 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BG - Bulgaria 4
EG - Egitto 4
MD - Moldavia 4
NO - Norvegia 4
SA - Arabia Saudita 4
DO - Repubblica Dominicana 3
EE - Estonia 3
GE - Georgia 3
HN - Honduras 3
KE - Kenya 3
KW - Kuwait 3
LV - Lettonia 3
MK - Macedonia 3
MY - Malesia 3
NP - Nepal 3
PY - Paraguay 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
UY - Uruguay 3
AM - Armenia 2
BO - Bolivia 2
BY - Bielorussia 2
HR - Croazia 2
JM - Giamaica 2
JO - Giordania 2
KH - Cambogia 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
RE - Reunion 2
VE - Venezuela 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CG - Congo 1
Totale 21.458
Salva come PNG Salva come JPEG
Città #
Chandler 1.553
Singapore 839
Ashburn 637
Dublin 506
Jacksonville 415
San Mateo 328
Nanjing 307
Jakarta 293
New York 266
Ann Arbor 234
Wilmington 209
Boston 208
Nürnberg 207
Milan 182
Princeton 175
Rome 162
Dearborn 158
Izmir 155
Moscow 154
Marseille 138
Los Angeles 137
Cattolica 136
Woodbridge 123
Warsaw 120
Helsinki 111
Houston 108
Nanchang 108
The Dalles 108
Chicago 101
Munich 100
Beijing 99
Seattle 95
Boardman 88
Bremen 84
Redwood City 84
Hefei 83
Fairfield 82
Brussels 70
Frankfurt am Main 68
Shenyang 67
Zhengzhou 67
Lancaster 63
Seoul 58
Kunming 57
Lawrence 56
Hebei 53
Changsha 49
Hangzhou 49
Norwalk 48
Guangzhou 43
Tianjin 43
University Park 42
Nuremberg 41
Mountain View 40
Redmond 40
Pune 39
Hyderabad 37
Kraków 37
São Paulo 37
Augusta 34
London 34
Abidjan 33
Vienna 33
Düsseldorf 32
Jiaxing 31
Jinan 31
San Jose 31
Shanghai 28
Toronto 28
Leawood 27
Hong Kong 26
Falkenstein 25
Santa Clara 24
Cambridge 23
Paris 23
Lauterbourg 22
Rio de Janeiro 21
San Diego 21
San Francisco 21
Fremont 20
North Bergen 20
Brno 19
Washington 19
Detroit 18
Portsmouth 17
Stockholm 17
Turku 17
Kish 16
Madrid 16
Amsterdam 15
Andover 15
Tokyo 15
Zurich 15
Bologna 14
Brooklyn 14
Belo Horizonte 13
Hanoi 13
Lanzhou 13
Ottawa 13
Taizhou 13
Totale 10.877
Salva come PNG Salva come JPEG
Nome #
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging 402
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 305
Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives. 263
Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features 218
A phase II study of sunitinib in advanced hepatocellular carcinoma 212
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 192
Long term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma <= 3 cm. Results of a multicenter Italian survey. 190
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 167
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 167
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 165
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 164
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 161
HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection 160
Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver 159
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 157
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 156
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 149
Ethanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm 146
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 146
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 143
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 141
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 136
recurrent acute hepatitis associated with use of cetrizine 134
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 132
A case of non-occlusive mesenteric ischemia and hepatic portal venous gas: not everyone knows that… 131
Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. 130
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 130
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 129
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 128
Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C group study 122
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 122
New signs and old applications of echo-color-Doppler should always be comapred to a gold-standard 117
[The treatment of hepatocellular carcinoma: an update] 116
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 115
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 115
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 115
Transarterial chemoembolization with degradable starch microspheres (DSM-TACE): an alternative option for advanced HCC patients? Preliminary results 115
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 113
Portal vein tumor thrombosis revascularization during sorafenib treatment for hepatocellular carcinoma 112
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 112
Evaluation of the albumin-gamma-glutamyl transferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. 109
Affective temperaments and psychopathological dimensions of personality in bipolar and cyclothymic patients 109
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection 108
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 108
Liver transplantation in patients with alcoholic liver disease: A retrospective study 108
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 106
Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study 106
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 105
Liver involvement in hereditary hemorrhagic telangiectasia: can breath test unmask impaired hepatic first-pass effect? 103
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers 103
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 102
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 102
Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches 101
Gastric wall thickness in normal and neoplastic subjects: a prospective study performed by abdominal ultrasound 101
Severe Skin Burn at Needle Entry Point Complicating Radiofrequency Ablation for Hepatocellular Carcinoma 101
DNA ploidy pattern in human chronic liver diseases and hepatic nodular lesions. Flow cytometric analysis on echo-guided needle liver biopsy 99
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation 99
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection 99
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 98
[Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients] 98
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers 98
Doppler ultrasonographic evaluation of blood flow in the superior mesenteric artery in celiac patients and in healthy controls in fasting conditions and after saccharose ingestion 97
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 97
Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma 96
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 96
Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis 95
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma 95
Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. 94
Sarilumab use in severe SARS-CoV-2 pneumonia 94
Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features 93
Lipohyperplasia of the ileocaecal valve as a cause of intestinal haemorrhage: an ultrasound Doppler study 92
Clinical suspicion of pancreatic neoplasm: does echo-guided fine-needle biopsy modify patient management? 92
Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes. 92
Single Hepatocellular Carcinoma Smaller than 2 cm: Are Ethanol Injection and Radiofrequency Ablation Equally Effective? 91
[Liver transplantation] 90
Amantadine-induced livedo reticularis occurring during treatment of chronic hepatitis C 89
Correlation Between QElaXto Techniques and Supersonic Imagine for Liver Stiffness Quantification in Chronic Liver Disease 89
Botulinum toxin-B ultrasound-guided injections for sialorrhea in amytrophic lateral sclerosis and Parkinson's disease 88
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 88
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 88
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 87
Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis 86
Combined locoregional treatment of patients with hepatocellular carcinoma: State of the art 86
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 86
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 86
A case of variant angina in a patient under chronic treatment with sorafenib 85
Contrast-enhanced power doppler of the intestinal wall in the evaluation of patients with Crohn disease 85
Liver transplantation in Italy: preliminary 10-year report. The Monotematica Aisf-Olt Study Group 84
Liver Stiffness in Pediatric Patients with Fatty Liver Disease: Diagnostic Accuracy and Reproducibility of Shear-Wave Elastography 84
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers 83
HEPATOCATT STUDY GROUP. Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (≤ 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging. 82
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 81
COVID-19-Related Social Isolation Predispose to Problematic Internet and Online Video Gaming Use in Italy 81
Is coeliac disease a confounding factor in the diagnosis of NASH? 80
Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation 80
Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment 80
Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms 80
Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report 80
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges. 80
Characterization of the gut-liver-muscle axis in cirrhotic patients with sarcopenia 80
Totale 11.862
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.523
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.523
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020370 0 0 0 0 0 0 0 0 0 0 194 176
2020/20211.564 98 170 16 149 194 58 156 24 228 92 317 62
2021/20222.119 143 170 38 128 130 55 43 316 76 156 391 473
2022/20234.704 620 587 387 665 298 560 248 400 527 103 191 118
2023/20242.534 117 694 96 122 114 379 136 95 31 160 235 355
2024/20254.290 131 133 474 204 402 198 206 328 782 494 938 0
Totale 21.824